| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 2647710
[patent_doc_number] => 04980456
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1990-12-25
[patent_title] => 'Recombinant factor VIIIC derived fragments'
[patent_app_type] => 1
[patent_app_number] => 7/034828
[patent_app_country] => US
[patent_app_date] => 1987-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5551
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/980/04980456.pdf
[firstpage_image] =>[orig_patent_app_number] => 034828
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/034828 | Recombinant factor VIIIC derived fragments | Apr 5, 1987 | Issued |
Array
(
[id] => 2568220
[patent_doc_number] => 04900720
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1990-02-13
[patent_title] => 'Replacement of human plasma using sterile solution of human plasma proteins excluding blood coagulation factors'
[patent_app_type] => 1
[patent_app_number] => 7/034468
[patent_app_country] => US
[patent_app_date] => 1987-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3558
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/900/04900720.pdf
[firstpage_image] =>[orig_patent_app_number] => 034468
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/034468 | Replacement of human plasma using sterile solution of human plasma proteins excluding blood coagulation factors | Apr 5, 1987 | Issued |
Array
(
[id] => 2596912
[patent_doc_number] => 04965251
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1990-10-23
[patent_title] => 'Pulse treatment of hemoglobinopathies with erythropoietin'
[patent_app_type] => 1
[patent_app_number] => 7/034309
[patent_app_country] => US
[patent_app_date] => 1987-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 4029
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/965/04965251.pdf
[firstpage_image] =>[orig_patent_app_number] => 034309
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/034309 | Pulse treatment of hemoglobinopathies with erythropoietin | Apr 2, 1987 | Issued |
| 07/032800 | ULTRAPURIFICATION PROCESS FOR POLYPEPTIDES | Mar 30, 1987 | Abandoned |
Array
(
[id] => 3099608
[patent_doc_number] => 05293023
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-03-08
[patent_title] => 'Laser irradiation nozzle and laser apparatus using the same'
[patent_app_type] => 1
[patent_app_number] => 7/030537
[patent_app_country] => US
[patent_app_date] => 1993-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 25
[patent_no_of_words] => 4462
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 200
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/293/05293023.pdf
[firstpage_image] =>[orig_patent_app_number] => 030537
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/030537 | Monoclonal antibodies against glycolipid antigens | Mar 26, 1987 | Issued |
Array
(
[id] => 3099608
[patent_doc_number] => 05293023
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-03-08
[patent_title] => 'Laser irradiation nozzle and laser apparatus using the same'
[patent_app_type] => 1
[patent_app_number] => 7/030537
[patent_app_country] => US
[patent_app_date] => 1993-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 25
[patent_no_of_words] => 4462
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 200
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/293/05293023.pdf
[firstpage_image] =>[orig_patent_app_number] => 030537
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/030537 | Monoclonal antibodies against glycolipid antigens | Mar 26, 1987 | Issued |
Array
(
[id] => 2545782
[patent_doc_number] => 04810634
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1989-03-07
[patent_title] => 'Pseudorabies virus mutants incapable of producing glycoprotein X'
[patent_app_type] => 1
[patent_app_number] => 7/049865
[patent_app_country] => US
[patent_app_date] => 1987-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9871
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/810/04810634.pdf
[firstpage_image] =>[orig_patent_app_number] => 049865
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/049865 | Pseudorabies virus mutants incapable of producing glycoprotein X | Mar 26, 1987 | Issued |
Array
(
[id] => 2860124
[patent_doc_number] => 05084559
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1992-01-28
[patent_title] => 'Protein A domain mutants'
[patent_app_type] => 1
[patent_app_number] => 7/032147
[patent_app_country] => US
[patent_app_date] => 1987-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6225
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/084/05084559.pdf
[firstpage_image] =>[orig_patent_app_number] => 032147
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/032147 | Protein A domain mutants | Mar 26, 1987 | Issued |
Array
(
[id] => 2603736
[patent_doc_number] => 04912201
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1990-03-27
[patent_title] => 'Monoclonal antibodies and antisera to intragonadal regulatory protein'
[patent_app_type] => 1
[patent_app_number] => 7/028816
[patent_app_country] => US
[patent_app_date] => 1987-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 35
[patent_no_of_words] => 22326
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/912/04912201.pdf
[firstpage_image] =>[orig_patent_app_number] => 028816
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/028816 | Monoclonal antibodies and antisera to intragonadal regulatory protein | Mar 25, 1987 | Issued |
Array
(
[id] => 2522779
[patent_doc_number] => 04861589
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1989-08-29
[patent_title] => 'Method for therapeutically treating abnormal cells expressing a major histocompatibility complex class II antigen using cytolytic inducer T4 cells'
[patent_app_type] => 1
[patent_app_number] => 7/028848
[patent_app_country] => US
[patent_app_date] => 1987-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 5
[patent_no_of_words] => 7494
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/861/04861589.pdf
[firstpage_image] =>[orig_patent_app_number] => 028848
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/028848 | Method for therapeutically treating abnormal cells expressing a major histocompatibility complex class II antigen using cytolytic inducer T4 cells | Mar 22, 1987 | Issued |
Array
(
[id] => 2563453
[patent_doc_number] => 04835260
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1989-05-30
[patent_title] => 'Erythropoietin composition'
[patent_app_type] => 1
[patent_app_number] => 7/028282
[patent_app_country] => US
[patent_app_date] => 1987-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2530
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/835/04835260.pdf
[firstpage_image] =>[orig_patent_app_number] => 028282
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/028282 | Erythropoietin composition | Mar 19, 1987 | Issued |
Array
(
[id] => 2518980
[patent_doc_number] => 04870159
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1989-09-26
[patent_title] => 'LEU3 gene sequence of S. cerevisiae and use in regulation of amino acid synthesis'
[patent_app_type] => 1
[patent_app_number] => 7/022974
[patent_app_country] => US
[patent_app_date] => 1987-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 4
[patent_no_of_words] => 4703
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/870/04870159.pdf
[firstpage_image] =>[orig_patent_app_number] => 022974
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/022974 | LEU3 gene sequence of S. cerevisiae and use in regulation of amino acid synthesis | Mar 5, 1987 | Issued |
| 07/021922 | HYBRIDOMA CELL LINE XMMBR-B14 | Mar 4, 1987 | Abandoned |
| 07/021669 | ACETYLATED LOW DENSITY LIPOPROTEIN & METHOD FOR DELIVERING MEDICATION THEREWITH TO DESIRED LOCATIONS | Mar 3, 1987 | Abandoned |
Array
(
[id] => 2564562
[patent_doc_number] => 04849509
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1989-07-18
[patent_title] => 'Monoclonal antibodies against melanoma-associated antigens and hybrid cell lines producing these antibodies'
[patent_app_type] => 1
[patent_app_number] => 7/016902
[patent_app_country] => US
[patent_app_date] => 1987-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7488
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/849/04849509.pdf
[firstpage_image] =>[orig_patent_app_number] => 016902
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/016902 | Monoclonal antibodies against melanoma-associated antigens and hybrid cell lines producing these antibodies | Feb 19, 1987 | Issued |
Array
(
[id] => 2552436
[patent_doc_number] => 04816249
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1989-03-28
[patent_title] => 'Monoclonal anti-idiotype antibodies'
[patent_app_type] => 1
[patent_app_number] => 7/016281
[patent_app_country] => US
[patent_app_date] => 1987-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4923
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/04/816/04816249.pdf
[firstpage_image] =>[orig_patent_app_number] => 016281
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/016281 | Monoclonal anti-idiotype antibodies | Feb 18, 1987 | Issued |
| 07/016356 | MONOCLONAL ANTIBODIES TO CRUCIFORM DNA STRUCTURE | Feb 18, 1987 | Abandoned |
| 07/014517 | BIFUNCTIONAL CHELATING AGENTS | Feb 12, 1987 | Abandoned |
| 07/014725 | NEW PROTEIN FOODS AND FOOD INGREDIENTS AND PROCESSES FOR PRODUCING THEM FROM DEFATTED AND UNDEFATTED OILSEEDS | Feb 12, 1987 | Abandoned |
| 07/014430 | SYNTHETIC PEPTIDES WHICH INDUCE CELLULAR IMMUNITY TO THE AIDS VIRUS AND AIDS VIRAL PROTEINS | Feb 11, 1987 | Abandoned |